GlassScriptPhysician profile
Charles Thomas Leewood
NPI 1306891395
$3,042.08
in general payments reported to CMS, 2019-2025
15 companies · $779 in 2025
The $779 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $422 · 2021: $258 · 2022: $370 · 2023: $670 · 2024: $264 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,713.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,146.36 | 2019-2025 | Affinity, Puraply Wound Matrix, Apligraf |
| Smith+Nephew, INC. | $889.12 | 2019-2025 | Collagenase Santyl, Pico, Renasys Touch |
| Next Science LLC | $211.56 | 2023 | Blastx, Xperience, Surgx |
| Kerecis Limited | $170.77 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $130.48 | 2020-2022 | |
| Misonix INC | $91.93 | 2020-2021 | |
| Kci USA, INC. | $90.16 | 2021-2023 | Activ.A.C., V.A.C.Instill, V.A.C. Dermatac |
| Mimedx Group, INC. | $77.95 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $71.30 | 2025 | |
| Osiris Therapeutics INC. | $58.59 | 2019 | |
| Solventum Corporation | $33.62 | 2025 | Promogran Prisma, Activ.A.C., V.A.C. Granufoam |
| Acera Surgical, INC. | $22.68 | 2023 | Restrata Wound Matrix |
| Bioventus LLC | $17.36 | 2023 | |
| Allergan, INC. | $15.82 | 2019 | |
| Hartmann USA, INC. | $14.38 | 2023 | Zetuvit Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Leewood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.